George Jerums
About
In The Last Decade
George Jerums
280 papers receiving 12.8k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Nephrology 4.8k
- Endocrinology, Diabetes and Metabolism 4.6k
- Cardiology and Cardiovascular Medicine 2.7k
- Clinical Biochemistry 2.2k
- Molecular Biology 2.1k
Countries citing papers authored by George Jerums
This map shows the geographic impact of George Jerums's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Jerums with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Jerums more than expected).
Fields of papers citing papers by George Jerums
This network shows the impact of papers produced by George Jerums. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Jerums. The network helps show where George Jerums may publish in the future.
Co-authorship network of co-authors of George Jerums
This figure shows the co-authorship network connecting the top 25 collaborators of George Jerums. A scholar is included among the top collaborators of George Jerums based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Jerums. George Jerums is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 11 | |
| 4 | 6 | |
| 5 | 30 | |
| 6 | 2 | |
| 7 | THE ROLE OF TUMOUR NECROSIS FACTOR RECEPTOR 1 (TNFR1) IN THE PROGRESSION OF KIDNEY DISEASE IN INDIGENOUS AUSTRALIANS: THE EGFR FOLLOW-UP STUDY | 2 |
| 8 | 16 | |
| 9 | Soluble Tnf receptors: a biomarker for Diabetic Kidney Disease? | 1 |
| 10 | 39 | |
| 11 | Accurate assessment of kidney function in Indigenous Australians: the Egfr Study | 2 |
| 12 | 14 | |
| 13 | 18 | |
| 14 | 67 | |
| 15 | Endocrinology - 3: Preventing complications of diabetes | 2 |
| 16 | 14 | |
| 17 | A multicenter double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesteremia | 1 |
| 18 | 54 | |
| 19 | 81 | |
| 20 | 10 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.